Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04294576
Title Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors (FIH)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BJ Bioscience, Inc.
Indications

head and neck squamous cell carcinoma

lung non-small cell carcinoma

cholangiocarcinoma

pancreatic cancer

stomach cancer

Advanced Solid Tumor

melanoma

Therapies

BJ-001 + Pembrolizumab

BJ-001

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Mount Sinai Recruiting New York New York 10029 United States Details
Greenville Hospital System University Medical Center (ITOR) Recruiting Greenville South Carolina 29605 United States Details
NEXT Oncology Recruiting San Antonio Texas 78229 United States Details
Northwest Medical Specialities Recruiting Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field